Clinical Trial

The Percutaneous Coronary Intervention Registry in University Medical Center of Ho Chi Minh City

Study acronym: UMC-PCI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 22, 2024 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
* This is a hospital-based registry study that will be to describe clinical and paraclinical features, procedural-related characteristics, short and long-term outcomes, hospital costs of patients undergoing percutaneous coronary intervention (PCI) at University Medical Center of Ho Chi Minh City (UMC), together with investigating predictors for patients' adverse clinical outcomes. * The specific objectives of this study are: * To validate a framework/model of PCI registry in UMC * To investigate the demographic, clinical of cardiovascular diseases and procedural characteristics of patient undergoing PCI in UMC * To investigate the procedural success, in-hospital adverse events and patient outcomes at one-month, three-month, twelve-month, three-year and five-year follow-up after PCI in UMC * To estimate in-hospital and procedural costs associated with PCI in UMC * To develop a prognostic prediction model for patients after PCI in UMC
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-01; most recent amendment 2024-05-20.
Trial Details
NCT Number NCT06071741
Lead Sponsor University Medical Center Ho Chi Minh City (UMC)
Conditions Coronary Artery Disease
Enrollment 3,600 participants
Start Date 2023-03-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2031-03-01 (estimated)
Updated on ClinicalTrials.gov 2024-05-22